OncologyTube.com is the first and only free video sharing website dedicated to helping oncology professionals spread knowledge about cancer research through video, audio and other multimedia.
    • OncologyTube Cancer Articles, News and Videos

      Site: OncologyTube Cancer Articles, News and Videos

    • 0
      • Portuguese
      • Spanish
      • Italian
      • Greek (Greece)
      • Sinhala
      • Polish
      • Arabic (Saudi Arabia)
      • Swedish (Sweden)
      • Portuguese (Brazil)
      • Hindi (India)
      • English (Australia)
      • Hebrew (Israel)
      • Czech
      • Hungarian (Hungary)
      • Chinese
      • Turkish
      • Japanese (Japan)
      • Dutch
      • French
      • German
      • Chinese (Traditional Han, Taiwan)
      • Korean (South Korea)
      • Thai
      • Spanish (Chile)
      • English (United States)
      • Russian
      • Danish (Denmark)
  • Home
  • Trending

  • Login

  • Quick Links
  • How To Self Record An Interview and Presentations
  • Schedule A Remote Interview!
  • Check Out Our Blog
  • Buy Advertising Banners
  • Buy Pre-Roll Advertisements
  • Boost Your Earned Media starting at Just $60
  • Create A Deep Dive Conversation
  • Advertising Specifications
  • Our Editorial Process
  • Publisher Calendar

  • Products & Pricing
  • Banner Advertising Plans
  • eNewsletter Packages
  • Pre-Roll Advertising
  • Create A Deep Dive Conversation
  • Create a Video Release (VR)
  • Boost Earned Media Only $60

  • Mobile
  • Connect Mobile App

  • Audio and Video
  • Videos
  • Audio

  • Channels
  • Browse Channels

  • Categories
  • Acute Lymphoblastic Leukemia 5595
  • Acute Myelogenous Leukemia 226
  • Bladder 96
  • Bone Metastases 5
  • Brain 79
  • Breast 562
  • Business Management 5
  • Cervical 16
  • Chronic Lymphocytic Leukemia 209
  • Chronic Myelogenous Leukemia 54
  • Colorectal 172
  • Conference Coverage 1
  • COVID-19 43
  • Gastrointestinal 177
  • General 341
  • Genitourinary 3
  • Head and Neck 110
  • Help 3
  • Hematologic Malignancies 206
  • Hodgkin Lymphoma 34
  • Imaging 2
  • Immunotherapy 179
  • Kidney 392
  • Liver 40
  • Lung 95
  • Lymphoma 235
  • Melanoma and Skin 107
  • Multiple Myeloma 535
  • Myeloproliferative Disease 37
  • News 149
  • Non-Hodgkin Lymphoma 81
  • Non-Small Cell Lung Cancer 554
  • Other 517
  • Ovarian 65
  • Pancreatic 104
  • Patient Resources 51
  • Pediatric 7
  • Prostate 300
  • Sarcoma 13
  • Sickle Cell 22
  • Small Cell Lung Cancer 81
  • Supportive Care 51
  • Testicular 3
  • Urology 16
  • Uterine 9

  • Install
  • Play a Link
  • About
  • Contact
  • Acute Lymphoblastic Leukemia
  • Acute Myelogenous Leukemia
  • Bladder
  • Bone Metastases
  • Brain
  • Breast
  • Business Management
  • Cervical
  • Chronic Lymphocytic Leukemia
  • Chronic Myelogenous Leukemia
  • Colorectal
  • Conference Coverage
  • COVID-19
  • Gastrointestinal
  • General
  • Genitourinary
  • Head and Neck
  • Help
  • Hematologic Malignancies
  • Hodgkin Lymphoma
  • Imaging
  • Immunotherapy
  • Kidney
  • Liver
  • Lung
  • Lymphoma
  • Melanoma and Skin
  • Multiple Myeloma
  • Myeloproliferative Disease
  • News
  • Non-Hodgkin Lymphoma
  • Non-Small Cell Lung Cancer
  • Other
  • Ovarian
  • Pancreatic
  • Patient Resources
  • Pediatric
  • Prostate
  • Sarcoma
  • Sickle Cell
  • Small Cell Lung Cancer
  • Supportive Care
  • Testicular
  • Urology
  • Uterine
Kazuhiko Matsuoka, PhD @MedUni_Wien Osteosarcoma (OS) is the most common form of aggressive bone cancer. A MedUni Vienna study, led by geneticist Erwin Wagner, has uncovered new insights ...
0:05:29

Kazuhiko Matsuoka, PhD @MedUni_Wien Osteosarcoma (OS) is ...

Kazuhiko Matsuoka, PhD Medical University of Vienna Osteosarcoma (OS) is the most common form of aggressive bone cancer. A MedUni Vienna study, led by geneticist Erwin Wagner, has uncovered new insights into the disease mechanisms of OS, paving the way for potential new diagnostic and treatment strategies for fighting the bone disease.

The most prevalent type of aggressive bone cancer is osteosarcoma (OS). New insights into the disease mechanisms of OS have been discovered in a MedUni Vienna study led by geneticist Erwin Wagner, paving the way for future new diagnosis and treatment methods for combating bone disease. The paper has just been published in Cell Research, a high-impact journal.

Normal osteosarcoma procedures include surgery for amputation and chemotherapy. While they are effective, they have a serious impact on the quality of life of patients. Patients with metastases and/or with surgical cancer have a very poor prognosis with a survival rate of around 20%. There is an urgent need for new clinical techniques to develop treatment approaches and prognoses — a problem which researchers have faced for over three decades.

The purpose is to create novel therapies directed at the underlying mechanisms of OS disease. The discovery of molecular diagnostic markers for early detection of relapse or metastasis is a big part of this, which will also lead to the production of new, more successful treatments.

The research used a number of models, including a genetically modified mouse model, mouse and human OS cell transplantation systems, and patient OS samples. The group of researchers from the Department of Dermatology and Laboratory Medicine at MedUni Vienna has discovered a biological mechanism in which high expression of the Fos / AP-1 transcription factor regulates the expression of a collagen-modifying matrix enzyme called LOXL2, through Wnt signaling.

In order to investigate the effects of Fos and LOXL2 on OS development, the researchers also carried out a series of experiments. "The results of this research strengthen our understanding of osteosarcoma disease mechanisms and pave the way for possible new diagnosis and treatment methods to combat this debilitating bone disease," said Kazuhiko Matsuoka, lead author of the research.
88 Views
2 years Ago
AACR
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

Bone Metastases

FAST-01: 2022 5 Key Takeaways [2022]
FAST-01: 2022 5 Key Takeaways [2022]
4 Views
4 months Ago
University of Cincinnati
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Podcast Ruben A. Mesa, MD @mpdrc @UTHealthSAMDA #ASCO22 #OncoTwitter @oncoalert Phase III MOMENTUM Study
0:09:16
Podcast Ruben A. Mesa, MD @mpdrc @UTHealthSAMDA #ASCO22 #...
9 Views
9 months Ago
Annual Meeting
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Ruben A. Mesa, MD @mpdrc @UTHealthSAMDA #ASCO22 #OncoTwitter @oncoalert Phase III MOMENTUM Study
0:09:16
Ruben A. Mesa, MD @mpdrc @UTHealthSAMDA #ASCO22 #OncoTwit...
25 Views
9 months Ago
Annual Meeting
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Kazuhiko Matsuoka, PhD @MedUni_Wien Osteosarcoma (OS) is the most common form of aggressive bone cancer. A MedUni Vienna study, led by geneticist Erwin Wagner, has uncovered new insights ...
0:05:29
Kazuhiko Matsuoka, PhD @MedUni_Wien Osteosarcoma (OS) is ...
88 Views
2 years Ago
AACR
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
If Practitioner Identifies Light-Chain Amyloidosis  Referring to Site Where Trial is Open is a Great Idea
00:00:40
If Practitioner Identifies Light-Chain Amyloidosis Refer...
260 Views
4 years Ago
Annual Meeting
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

comments@oncologytube.com Copyright 2023 Medicus Networks, Inc. 45121 Morgan Heights Rd. Temecula, CA 92592 - (951) 326-8827